What it's sold for
- Soft-tissue & tendon recovery
- Injury healing
- Hair growth
What has actually been tested
- Atherosclerotic Cardiovascular Diseases
- Endothelial Dysfunction
Is it studied for what it's sold for?
Each claim below is matched against the condition and title fields of every registered trial. Not listed means no trial names it as a studied condition — not that it has been disproven, and not that no trial touches it indirectly.
Every trial on record
Every registered human study we can find for TB-500. Click any ID to read the original record — we would rather you checked us than trusted us.
| Trial ID | Title | Condition | Phase | Status | Enrolled |
|---|---|---|---|---|---|
| NCT07487363 | TB-500 (Thymosin Beta 4 17-23 Fragment) for Cardiovascular Biomarkers in Stable ASCVD | Atherosclerotic Cardiovascular Diseases, Endothelial Dysfunction | Phase 2 | Recruiting now | 80 |
Common questions about TB-500
How many human trials does TB-500 have?
1. That is the number of registered interventional human studies we can find, each listed on this page with a link to its original record.
Is TB-500 FDA approved?
No. TB-500 is not approved by the FDA for any indication. Compounded or "research use only" preparations are not FDA-approved and receive no premarket review for safety, effectiveness, or manufacturing quality.
What is TB-500 actually being tested for?
Registered studies cover: atherosclerotic cardiovascular diseases, endothelial dysfunction. Compare that to what it is marketed for — the two lists are often different, which is the whole point of this page.
Where does this data come from?
ClinicalTrials.gov, the US public registry of clinical studies. We count interventional human studies only — observational studies are not evidence of effect. Every trial on this page links to its original record so you can check us rather than trust us.
Get told when this changes
One email a week: what moved in the research, and which claims the record doesn't support. Free, and you can leave in one click.